{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T03:16:39Z","timestamp":1781838999285,"version":"3.54.5"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,13]],"date-time":"2020-12-13T00:00:00Z","timestamp":1607817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007210","name":"Varian Medical Systems","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007210","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.radonc.2020.12.013","type":"journal-article","created":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T09:34:35Z","timestamp":1607679275000},"page":"145-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Single-fraction prostate stereotactic body radiotherapy: Dose reconstruction with electromagnetic intrafraction motion tracking"],"prefix":"10.1016","volume":"156","author":[{"given":"Maud","family":"Jaccard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2471-1259","authenticated-orcid":false,"given":"Stefanie","family":"Ehrbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Miralbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4425-4945","authenticated-orcid":false,"given":"Tobias","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Koutsouvelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9940-7609","authenticated-orcid":false,"given":"Per","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Rouzaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Tanadini-Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pelagia","family":"Tsoutsou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7146-9071","authenticated-orcid":false,"given":"Matthias","family":"Guckenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4784-9883","authenticated-orcid":false,"given":"Thomas","family":"Zilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2020.12.013_b0005","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(19)31131-6","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial","volume":"394","author":"Widmark","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2020.12.013_b0010","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.ijrobp.2019.03.051","article-title":"Stereotactic body radiation therapy for localized prostate cancer: a systematic review and meta-analysis of over 6,000 patients treated on prospective studies","volume":"104","author":"Jackson","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.12.013_b0015","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S1470-2045(19)30569-8","article-title":"Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial","volume":"20","author":"Brand","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2020.12.013_b0020","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.radonc.2020.04.037","article-title":"Ultrahypofractionated versus hypofractionated and conventionally fractionated radiation therapy for localized prostate cancer: a systematic review and meta-analysis of phase III randomized trials","volume":"148","author":"Lehrer","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.12.013_b0025","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1002\/cam4.2966","article-title":"Once-a-week or every-other-day urethra-sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow-up results","volume":"9","author":"Zilli","year":"2020","journal-title":"Cancer Medicine"},{"key":"10.1016\/j.radonc.2020.12.013_b0030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.radonc.2019.08.027","article-title":"ESTRO ACROP consensus guideline on the use of image guided radiation therapy for localized prostate cancer","volume":"141","author":"Ghadjar","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.12.013_b0035","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.adro.2017.03.003","article-title":"ACR Appropriateness Criteria for external beam radiation therapy treatment planning for clinically localized prostate cancer, part II of II","volume":"2","author":"Zaorsky","year":"2017","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2020.12.013_b0040","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2007.11.054","article-title":"Observations on real-time prostate gland motion using electromagnetic tracking","volume":"71","author":"Langen","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.12.013_b0045","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ijrobp.2005.12.033","article-title":"Influence of intrafraction motion on margins for prostate radiotherapy","volume":"65","author":"Litzenberg","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.12.013_b0050","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0360-3016(01)02823-1","article-title":"Measurements and clinical consequences of prostate motion during a radiotherapy fraction","volume":"53","author":"Nederveen","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.12.013_b0055","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ijrobp.2007.10.049","article-title":"Dosimetric consequences of intrafraction prostate motion","volume":"71","author":"Li","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.12.013_b0060","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ijrobp.2006.01.050","article-title":"Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer","volume":"65","author":"Willoughby","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.12.013_b0065","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ijrobp.2006.10.026","article-title":"Multi-institutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy","volume":"67","author":"Kupelian","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.12.013_b0070","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/j.prro.2020.03.003","article-title":"Electromagnetic transponder localization and real-time tracking for prostate cancer radiation therapy: clinical impact of metallic hip prostheses","volume":"10","author":"Bottero","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2020.12.013_b0075","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13014-018-1112-0","article-title":"ONE SHOT - single shot radiotherapy for localized prostate cancer: study protocol of a single arm, multicenter phase I\/II trial","volume":"13","author":"Zilli","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2020.12.013_b0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.radonc.2019.07.018","article-title":"Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial","volume":"139","author":"Zilli","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.12.013_b0085","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0360-3016(94)90011-6","article-title":"Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer","volume":"30","author":"Diaz","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.12.013_b0090","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1016\/j.ijrobp.2012.01.023","article-title":"Pelvic normal tissue contouring guidelines for radiation therapy: a radiation therapy oncology group consensus panel atlas","volume":"83","author":"Gay","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.12.013_b0095","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1118\/1.4754297","article-title":"A method of dose reconstruction for moving targets compatible with dynamic treatments: dose reconstruction for moving targets","volume":"39","author":"Poulsen","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2020.12.013_b0100","first-page":"145","article-title":"A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancer","volume":"8","author":"Avkshtol","year":"2016","journal-title":"Res Rep Urol"},{"key":"10.1016\/j.radonc.2020.12.013_b0105","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.adro.2019.09.010","article-title":"Gantry-mounted linear accelerator-based stereotactic body radiation therapy for low- and intermediate-risk prostate cancer","volume":"5","author":"Dang","year":"2020","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2020.12.013_b0110","doi-asserted-by":"crossref","first-page":"15TR01","DOI":"10.1088\/1361-6560\/ab2ba8","article-title":"Real-time intrafraction motion monitoring in external beam radiotherapy","volume":"64","author":"Bertholet","year":"2019","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2020.12.013_b0115","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00539","article-title":"Clinical assessment of prostate displacement and planning target volume margins for stereotactic body radiotherapy of prostate cancer","volume":"10","author":"Levin-Epstein","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2020.12.013_b0120","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.radonc.2020.06.044","article-title":"Prostate intrafraction motion during the preparation and delivery of MR-guided radiotherapy sessions on a 1.5T MR-Linac","volume":"151","author":"de Muinck Keizer","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.12.013_b0125","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.zemedi.2019.12.004","article-title":"Evaluation of intrafraction prostate motion tracking using the Clarity Autoscan system for safety margin validation","volume":"30","author":"Richter","year":"2020","journal-title":"Zeitschrift f\u00fcr Medizinische Physik"},{"issue":"3","key":"10.1016\/j.radonc.2020.12.013_b0130","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.radonc.2014.05.007","article-title":"Kilovoltage intrafraction motion monitoring and target dose reconstruction for stereotactic volumetric modulated arc therapy of tumors in the liver","volume":"111","author":"Poulsen","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.12.013_b0135","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejmp.2020.06.010","article-title":"Dosimetric effect of intrafraction motion and different localization strategies in prostate SBRT","volume":"75","author":"Vanhanen","year":"2020","journal-title":"Physica Med"},{"key":"10.1016\/j.radonc.2020.12.013_b0140","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ijrobp.2020.03.014","article-title":"Real-time image guided ablative prostate cancer radiation therapy: results from the TROG 15.01 SPARK trial","volume":"107","author":"Keall","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.12.013_b0145","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/mp.12236","article-title":"Validation of dynamic treatment-couch tracking for prostate SBRT","volume":"44","author":"Ehrbar","year":"2017","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2020.12.013_b0150","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/acm2.12684","article-title":"Calculation of delivered composite dose from Calypso tracking data for prostate cancer: and subsequent evaluation of reasonable treatment interruption tolerance limits","volume":"20","author":"Zhao","year":"2019","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2020.12.013_b0155","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.3109\/0284186X.2015.1062134","article-title":"Respiratory gating based on internal electromagnetic motion monitoring during stereotactic liver radiation therapy: first results","volume":"54","author":"Poulsen","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2020.12.013_b0160","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.radonc.2019.11.008","article-title":"Simulated multileaf collimator tracking for stereotactic liver radiotherapy guided by kilovoltage intrafraction monitoring: dosimetric gain and target overdose trends","volume":"144","author":"Poulsen","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.12.013_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2020.08.010","article-title":"Is multileaf collimator tracking or gating a better intrafraction motion adaptation strategy? An analysis of the TROG 15.01 Stereotactic Prostate Ablative Radiotherapy with KIM (SPARK) trial","author":"Hewson","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.12.013_b0170","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.radonc.2019.07.007","article-title":"First clinical real-time motion-including tumor dose reconstruction during radiotherapy delivery","volume":"139","author":"Skouboe","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.12.013_b0175","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1002\/mp.13792","article-title":"Simulated real-time dose reconstruction for moving tumors in stereotactic liver radiotherapy","volume":"46","author":"Skouboe","year":"2019","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2020.12.013_b0180","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.phro.2020.06.005","article-title":"Delivered dose quantification in prostate radiotherapy using online 3D cine imaging and treatment log files on a combined 1.5T magnetic resonance imaging and linear accelerator system","volume":"15","author":"Kontaxis","year":"2020","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.radonc.2020.12.013_b0185","doi-asserted-by":"crossref","first-page":"6531","DOI":"10.1118\/1.4722968","article-title":"It is not appropriate to \u201cdeform\u201d dose along with deformable image registration in adaptive radiotherapy","volume":"39","author":"Schultheiss","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2020.12.013_b0190","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3109\/0284186X.2014.928742","article-title":"Evaluation of an application for intensity-based deformable image registration and dose accumulation in radiotherapy","volume":"53","author":"Thor","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2020.12.013_b0195","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1002\/mp.12256","article-title":"Use of image registration and fusion algorithms and techniques in radiotherapy: report of the AAPM Radiation Therapy Committee Task Group No. 132","volume":"44","author":"Brock","year":"2017","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2020.12.013_b0200","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1080\/0284186X.2019.1620331","article-title":"Deformable image registration for radiation therapy: principle, methods, applications and evaluation","volume":"58","author":"Rigaud","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2020.12.013_b0205","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0360-3016(02)03790-2","article-title":"Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas","volume":"55","author":"Khalil","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.12.013_b0210","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2012.08.008","article-title":"QA makes a clinical trial stronger: evidence-based medicine in radiation therapy","volume":"105","author":"Weber","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.12.013_b0215","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.ijrobp.2020.06.002","article-title":"Urethra-sparing stereotactic body radiation therapy for prostate cancer: quality assurance of a randomized phase 2 trial","volume":"108","author":"Jaccard","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.12.013_b0220","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1200\/JCO.2009.21.8529","article-title":"Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411","volume":"27","author":"Crane","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2020.12.013_b0225","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1200\/JCO.2001.19.11.2905","article-title":"Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin\u2019s disease: long-term results of a randomized trial of radiotherapy alone","volume":"19","author":"D\u00fchmke","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2020.12.013_b0230","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ijrobp.2010.11.039","article-title":"Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704\u2014A phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas","volume":"82","author":"Abrams","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.12.013_b0235","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1200\/JCO.2009.27.4498","article-title":"Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02","volume":"28","author":"Peters","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2020.12.013_b0240","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.ijrobp.2009.04.011","article-title":"Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00\u201322)","volume":"76","author":"Eisbruch","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.12.013_b0245","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/1754-9485.12025","article-title":"Quality improvements in prostate radiotherapy: outcomes and impact of comprehensive quality assurance during the TROG 03.04 \u2018RADAR\u2019 trial","volume":"57","author":"Kearvell","year":"2013","journal-title":"J Med Imaging Radiat Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814020312329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814020312329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:13:44Z","timestamp":1759122824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814020312329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":49,"alternative-id":["S0167814020312329"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2020.12.013","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-fraction prostate stereotactic body radiotherapy: Dose reconstruction with electromagnetic intrafraction motion tracking","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2020.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}